Description
I am a Medical Scientist with extensive clinical development experience and a proven track record of successful contributions to the approval of multiple new drug applications (NDA/BLA). I have a strong foundation of global drug development and extensive experience conducting clinical trials in accordance with local, country-level and global standards. My experiences range evenly from early to late stage clinical development of therapeutics and diagnostics. I have supported a wide range of therapeutic areas including neurosciences, hematology/ oncology, immune-oncology, endocrinology, cardiovascular and immunology. I have lead cross functional teams in the development of therapeutics with companion devices and diagnostics. In my current role, I am the Global Lead of a Phase III study in HER2 amplified metastatic breast cancer. In this role, I oversee the program strategy and uphold the scientific and technical integrity of the study. I have established and maintain close collaborations with internal and external stakeholders including cross-functional team members, clinical investigators, key opinion leaders and regulatory agencies.
Accomplishments
Highlights:
Keywords
